What is Tapemark?
Tapemark, a privately held contract manufacturer based in West St. Paul, Minnesota, boasts over five decades of experience in developing and implementing innovative technologies tailored to specific client needs. The company operates multiple facilities and adheres to stringent quality standards, holding cGMP-compliant, ISO 9001, and 13485 certifications. Tapemark is also FDA registered for drug, device, food, and cosmetic contract manufacturing. Its integrated converting capabilities, including coating, printing, die cutting, and packaging, serve critical components and products for the medical, pharmaceutical, and consumer goods industries, positioning it as a key player in these demanding markets.
How much funding has Tapemark raised?
Tapemark has raised a total of $2M across 1 funding round:
Debt
$2M
Debt (2020): $2M with participation from PPP
What's next for Tapemark?
The substantial enterprise-level backing and recent strategic investment signal a period of accelerated growth and potential expansion for Tapemark. This capital infusion is likely to fuel further technological advancements, enhance manufacturing capacities, and potentially broaden its market reach within the highly regulated medical, pharmaceutical, and consumer product sectors. Tapemark's focus on quality and compliance, combined with its diverse converting capabilities, positions it to capitalize on emerging opportunities and solidify its leadership in contract manufacturing.
See full Tapemark company page
